Search Results 2131-2140 of 17029 for glomerulonephritis.
Latest stories · Delivering innovative stem cell therapy to slow vision loss featured image · Mayo Clinic Q&A podcast: Addressing disparities to prevent disease ...
Julie Ferris-Tillman, Ph.D. January 21, 2026. New CT imaging oral contrast agent improves visualization of bowel anatomy, clinical trial ...
Safety and Efficacy of Simtuzumab (GS-6624) in Adults With Advanced Liver Fibrosis But Not Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH) · Overview.
Clinicians at Mayo Clinic can use artificial intelligence (AI) tools to effectively screen patients for a weak heart pump via a simple electrocardiogram ...
According to the Centers for Disease Control and Prevention, flu infection rates across the U.S. continue to be very high. "As we predicted, this flu season[...].
Research · New oral anticoagulant drugs associated with lower kidney risks, Mayo Clinic research shows featured image · Science Saturday: Where future cures come ...
Research at Mayo Clinic in diabetic nephropathy includes developing new diagnostic and treatment tools, such as oral medicines that may help stop or delay the ...
Chimeric antigen receptor-T cell therapy (CAR-T cell therapy) could provide a revolutionary approach to organ transplantation for patients who are hard to match ...
ROCHESTER, Minn. — A single 25 mg dose of a combination of amphetamine-dextroamphetamine salts (Adderall) can have measurable cardiovascular effects in ...
Strategic collaboration brings together Mayo Clinic's extensive clinical insights, genomic data and Platform architecture with Merck's artificial ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.